|
|
|||||
|
|
|
|
|
|
|
|
|
|||||
|
|
|||||
|
Planned for commercial release in 2008, the Clean CollectTM Blood Collection System will set an entirely new standard for the collection of blood samples for diagnostic culturing. Based on current research, an average reduction of 50% in the contamination rate of blood culture samples is predicted with the use of Clean CollectTM. The impact of this reduction will be tremendous, saving hospitals millions of dollars each year. Click here for a product overview.
ReactiSeptTM is a development stage product line being designed to detect microorganisms in blood and body fluid samples in a fraction of the time required by conventional culturing methods. ReactiSeptTM is expected to first join and then replace blood culturing as the primary test for the detection of septicemia.
|
|||||
|
Home | Entrepreneurs | Research | Clinical Laboratories | Careers | About Us Contact Us | Latest News | Investor Relations
|
|||||
|
Stone Medical Corporation © 2007 All Rights Reserved. |
|||||
ReactiSeptTM
Rapid Detection Systems